ENTITY
Eisai Co Ltd

Eisai Co Ltd (4523 JP)

101
Analysis
Health CareJapan
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
more
Refresh
21 Sep 2017 05:03

Large-Cap Names that Have Gotten a Lot More Volatile Recently....

We screened for large-cap names in Japan that have recently seen a spike in volatility. We calculated Beta over the last 6 months and compared it...

Logo
271 Views
Share
bearishDaiichi Sankyo
14 Sep 2017 07:49

Daiichi Sankyo (4568 JP) Releases Phase I Data for DS-8201 at ESMO 2017

Daiichi Sankyo [DSK] (4568 JP) released Phase I data for DS-8201 at ESMO 2017 as follows: 32% overall response rate, 82% disease control rate. The...

bullishCatalent Inc
04 Sep 2017 07:24

New Stem Cell Treatment for Parkinsons Positive for Catalent and Eisai

A pioneering new stem cell treatment with the 'potential to cure Parkinson's disease' has been crafted by researchers. In trials on laboratory...

04 Sep 2017 07:23

Fujifilm - Unloved, but Not Unlovable

When we visited Fujifilm Holdings Corp (4901 JP), recently, our contact did not appear particularly pleased about an article the Nikkei ran on the...

27 Jul 2017 07:30

Mitsubishi Tanabe (4508) - Acquisition of NeuroDerm Playing to Strength, Not Weakness

The history of overseas acquisitions by Japanese drug companies is not a pretty one, as they've either overpaid for a skillset (Takeda (4502 JP)...

x